Skip to content
2000
Volume 22, Issue 1
  • ISSN: 1567-2018
  • E-ISSN: 1875-5704

Abstract

Background

The therapeutic effect of NS oil in mild to moderate psoriasis is limited owing to low play load of thymoquinone (<15%w/w), irritation, dripping, low viscosity and thus, less contact time on the lesions.

Aims

This study aimed at developing and characterizing the ethanolic vesicular hydrogel system of (NS) oil (NS EV hydrogel) for the enhancement of anti-psoriatic activity.

Objective

The objective of this study was to develop NS EV hydrogel and evaluate its anti-psoriatic activity.

Methods

The identification and quantification of TQ content in different NS seed extracts and marketed oil were measured by an HPTLC method using n-hexane and ethyl acetate as solvent systems. Preparation of ethanolic vesicles (EVs) was performed by solvent injection method, while its anti-psoriatic activity was evaluated employing an Imiquad (IMQ)-induced plaque psoriasis animal model.

Results

A compact HPTLC band was obtained for TQ at an value of 0.651. The calibration plot was linear in the range of 1-10 µg/spot, and the correlation coefficient of 0.990 was indicative of good linear dependence of peak area on concentration. From the different NS sources, the high TQ content was obtained in the marketed cold press oil, ., 1.45±0.08 mg/ml. Out of various NS oil-loaded EVs, the F6 formulation revealed the smallest particle size (278.1 nm), with log-normal size distribution (0.459) and adequate entrapment efficiency. A non-uniform shape was observed in the transmission electron microscopy. The viscosity of F6 formulation hydrogel was 32.34 which exhibited plastic behavior. efficacy studies demonstrated decreased inflammation of the epidermis and dermis and a marked decrease in the levels of IL-17 by NS EV hydrogel compared to plain NS oil and standard drugs (Betamethasone and Dr. JRK Psorolin Oil).

Conclusion

It may be concluded from the findings that NS-loaded EV gel was as good as betamethasone cream but more efficacious than the other treatments.

Loading

Article metrics loading...

/content/journals/cdd/10.2174/0115672018246645231019131748
2024-07-02
2024-12-26
Loading full text...

Full text loading...

References

  1. RamadanM.F. Nutritional value, functional properties and nutraceutical applications of black cumin (Nigella sativa L.): An overview.Int. J. Food Sci. Technol.200742101208121810.1111/j.1365‑2621.2006.01417.x
    [Google Scholar]
  2. EidA.M. A review on the cosmeceutical and external applications of Nigella sativa.J. Trop. Med.201720177092514
    [Google Scholar]
  3. Yamanİ. BalikciE. Protective effects of nigella sativa against gentamicin-induced nephrotoxicity in rats.Exp. Toxicol. Pathol.201062218319010.1016/j.etp.2009.03.006 19398313
    [Google Scholar]
  4. AliB. BlundenG. Pharmacological and toxicological properties of Nigella sativa.Phytother. Res.200317429930510.1002/ptr.1309
    [Google Scholar]
  5. ChandrasekarR. SivagamiB. Alternative treatment for psoriasis-A review.Int. J. Res. Dev. Pharm. Life Sci.20165421882197
    [Google Scholar]
  6. ThakurS. KauravH. ChaudharyG. Nigella sativa (Kalonji): A black seed of miracle.Int. J. Res. Rev.20218434235710.52403/ijrr.20210441
    [Google Scholar]
  7. MichalekI.M. LoringB. JohnS.M. A systematic review of worldwide epidemiology of psoriasis.J. Eur. Acad. Dermatol. Venereol.201731220521210.1111/jdv.13854 27573025
    [Google Scholar]
  8. SunL. LiuZ. LinZ. CunD. TongH. YanR. WangR. ZhengY. Comparison of normal versus imiquimod-induced psoriatic skin in mice for penetration of drugs and nanoparticles.Int. J. Nanomedicine2018135625563510.2147/IJN.S170832 30271151
    [Google Scholar]
  9. Mascarenhas-MeloF. CarvalhoA. GonçalvesM.B.S. Paiva-SantosA.C. VeigaF. Nanocarriers for the topical treatment of psoriasis - pathophysiology, conventional treatments, nanotechnology, regulatory and toxicology.Eur. J. Pharm. Biopharm.20221769510710.1016/j.ejpb.2022.05.012 35605927
    [Google Scholar]
  10. PradhanM. AlexanderA. SinghM.R. SinghD. SarafS. SarafS. Ajazuddin, Understanding the prospective of nano-formulations towards the treatment of psoriasis.Biomed. Pharmacother.201810744746310.1016/j.biopha.2018.07.156 30103117
    [Google Scholar]
  11. MartinG. YoungM. AldredgeL. Recommendations for initiating systemic therapy in patients with psoriasis.J. Clin. Aesthet. Dermatol.20191241326 31119006
    [Google Scholar]
  12. JainA. DoppalapudiS. DombA.J. KhanW. Tacrolimus and curcumin co-loaded liposphere gel: Synergistic combination towards management of psoriasis.J. Control. Release201624313214510.1016/j.jconrel.2016.10.004 27725194
    [Google Scholar]
  13. DadwalA. MishraN. NarangR.K. Novel topical nanocarriers for treatment of psoriasis: An overview.Curr. Pharm. Des.201924333934395010.2174/1381612824666181102151507 30387390
    [Google Scholar]
  14. YadavK. SinghD. SinghM.R. Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies.Eur. J. Pharmacol.202190717425410.1016/j.ejphar.2021.174254 34118225
    [Google Scholar]
  15. HwangJ.R. CartronA.M. KhachemouneA. A review of Nigella sativa plant‐based therapy in dermatology.Int. J. Dermatol.20216012e493e49910.1111/ijd.15615 33899217
    [Google Scholar]
  16. OkashaE.F. BayomyN.A. AbdelazizE.Z. Effect of topical application of black seed oil on imiquimod‐induced psoriasis‐like lesions in the thin skin of adult male albino rats.Anat. Rec.2018301116617410.1002/ar.23690 28926201
    [Google Scholar]
  17. PalaniswamyD. NithyananthamM. RaghuP.S. DwarampudiL.P. Antipsoriatic activity and cytotoxicity of ethanolic extract of Nigella sativa seeds.Pharmacogn. Mag.201283226827210.4103/0973‑1296.103650 24082629
    [Google Scholar]
  18. Ahmed JawadH. Ibraheem AzharY. Al-Hamdi KhalilI. Evaluation of efficacy, safety and antioxidant effect of Nigella sativa in patients with psoriasis: A randomized clinical trial.J Clin Exp Invest20145218619310.5799/ahinjs.01.2014.02.0387
    [Google Scholar]
  19. ZhengY. ZhangQ. HuX. A comprehensive review of ethnopharmacological uses, phytochemistry, biological activities, and future prospects of Nigella glandulifera.Med. Chem. Res.20202971168118610.1007/s00044‑020‑02558‑9
    [Google Scholar]
  20. RathoreC. RathboneM.J. ChellappanD.K. TambuwalaM.M. PintoT.D.J.A. DurejaH. HemrajaniC. GuptaG. DuaK. NegiP. Nanocarriers: More than tour de force for thymoquinone.Expert Opin. Drug Deliv.202017447949410.1080/17425247.2020.1730808 32077770
    [Google Scholar]
  21. AlexanderA. Ajazuddin; Patel, R.J.; Saraf, S.; Saraf, S. Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives.J. Control. Release201624111012410.1016/j.jconrel.2016.09.017 27663228
    [Google Scholar]
  22. RoshiniR. SaraswathiT. XdamodharanieM. Ethosomes: Novel lipid vesicular and non-invasive delivery carrier–A review.J. Posit. Sch. Psychol.20226840994111
    [Google Scholar]
  23. VermaP. PathakK. Therapeutic and cosmeceutical potential of ethosomes: An overview.J. Adv. Pharm. Technol. Res.20101327428210.4103/0110‑5558.72415 22247858
    [Google Scholar]
  24. NegiP. SinghB. SharmaG. KatareO.P. Enhanced topical delivery of lidocaine via ethosomes-based hydrogel: Ex-vivo and in-vivo evaluation.J. Nanopharm. Drug Deliv.20142213814710.1166/jnd.2014.1054
    [Google Scholar]
  25. KumariS. GoyalA. Sönmez GürerE. Algın YaparE. GargM. SoodM. SindhuR.K. Bioactive loaded novel nano-formulations for targeted drug delivery and their therapeutic potential.Pharmaceutics2022145109110.3390/pharmaceutics14051091 35631677
    [Google Scholar]
  26. NegiP. SharmaI. HemrajaniC. RathoreC. BishtA. RazaK. KatareO.P. Thymoquinone-loaded lipid vesicles: A promising nanomedicine for psoriasis.BMC Complement. Altern. Med.201919133410.1186/s12906‑019‑2675‑5 31771651
    [Google Scholar]
  27. AlamP. YusufogluH. AlamA. HPTLC densitometric method for analysis of thymoquinone in Nigella sativa extracts and marketed formulations.Asian Pac. J. Trop. Dis.20133646747110.1016/S2222‑1808(13)60102‑4
    [Google Scholar]
  28. Velho-PereiraR.M. BarhateC.R. KulkarniS.R. JagtapA.G. Validated high-performance thin-layer chromatographic method for the quantification of thymoquinone in Nigella Sativa extracts and formulations.Phytochem. Anal.201122436737310.1002/pca.1289 21337651
    [Google Scholar]
  29. RazaK. SinghB. LohanS. SharmaG. NegiP. YachhaY. KatareO.P. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.Int. J. Pharm.20134561657210.1016/j.ijpharm.2013.08.019 23973754
    [Google Scholar]
  30. Abd El-AlimS.H. KassemA.A. BashaM. SalamaA. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: in vitro and in vivo evaluation.Int. J. Pharm.201956329330310.1016/j.ijpharm.2019.04.001 30951860
    [Google Scholar]
  31. RazaK. SinghB. MahajanA. NegiP. BhatiaA. KatareO.P. Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin.J. Drug Target.201119429330210.3109/1061186X.2010.499464 20615093
    [Google Scholar]
  32. NegiP. SinghB. SharmaG. BegS. RazaK. KatareO.P. Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation.Drug Deliv.201623394195710.3109/10717544.2014.923067 24892623
    [Google Scholar]
  33. AgrawalM. SarafS. PradhanM. PatelR.J. SinghviG. Ajazuddin; Alexander, A. Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design.Biomed. Pharmacother.202114111191910.1016/j.biopha.2021.111919 34328108
    [Google Scholar]
  34. JainS. PatelN. MadanP. LinS. Formulation and rheological evaluation of ethosome-loaded carbopol hydrogel for transdermal application.Drug Dev. Ind. Pharm.20164281315132410.3109/03639045.2015.1132227 26727599
    [Google Scholar]
  35. NegiP. AggarwalM. SharmaG. RathoreC. SharmaG. SinghB. KatareO.P. Niosome-based hydrogel of resveratrol for topical applications: An effective therapy for pain related disorder(s).Biomed. Pharmacother.20178848048710.1016/j.biopha.2017.01.083 28126673
    [Google Scholar]
  36. BadanthadkaM. D’SouzaL. Imiquimod-induced psoriasis mice model: A promising tool for psoriasis research?Res J Pharm Technol20201373508351510.5958/0974‑360X.2020.00621.6
    [Google Scholar]
  37. ChandraA. AggarwalG. ManchandaS. NarulaA. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis.Pharm. Nanotechnol.20197536237410.2174/2211738507666190906123643 31490769
    [Google Scholar]
  38. TouitouE. DayanN. BergelsonL. GodinB. EliazM. Ethosomes — novel vesicular carriers for enhanced delivery: Characterization and skin penetration properties.J. Control. Release200065340341810.1016/S0168‑3659(99)00222‑9 10699298
    [Google Scholar]
  39. GargB.J. GargN.K. BegS. SinghB. KatareO.P. Nanosized ethosomes-based hydrogel formulations of methoxsalen for enhanced topical delivery against vitiligo: Formulation optimization, in vitro evaluation and preclinical assessment.J. Drug Target.201624323324610.3109/1061186X.2015.1070855 26267289
    [Google Scholar]
  40. van der FitsL. MouritsS. VoermanJ.S.A. KantM. BoonL. LamanJ.D. CornelissenF. MusA.M. FlorenciaE. PrensE.P. LubbertsE. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.J. Immunol.200918295836584510.4049/jimmunol.0802999 19380832
    [Google Scholar]
  41. MostafaM. AlaaeldinE. AlyU.F. SarhanH.A. Optimization and characterization of thymoquinone-loaded liposomes with enhanced topical anti-inflammatory activity.AAPS PharmSciTech20181983490350010.1208/s12249‑018‑1166‑1 30218265
    [Google Scholar]
  42. JainA. PooladandaV. BulbakeU. DoppalapudiS. RafeeqiT.A. GoduguC. KhanW. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis.Nanomedicine20171372251226210.1016/j.nano.2017.06.009 28647592
    [Google Scholar]
  43. DoppalapudiS. JainA. ChopraD.K. KhanW. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis.Eur. J. Pharm. Sci.20179651552910.1016/j.ejps.2016.10.025 27777066
    [Google Scholar]
/content/journals/cdd/10.2174/0115672018246645231019131748
Loading
/content/journals/cdd/10.2174/0115672018246645231019131748
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): ethanolic vesicles; imiquad; micromeritics; Nigella sativa; psoriasis; thymoquinone
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test